Precision Biosciences earnings were -$45.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest DTIL earnings report on Dec 31, 2025 announced Q4 2025 earnings of $20.1M, down 192.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DTIL reported annual earnings of -$45.7M, with -738% growth.
Precision Biosciences Earnings Reports & History FAQ
What were Precision Biosciences's earnings last quarter?
Precision Biosciences (NASDAQ: DTIL) reported Q4 2025 earnings per share (EPS) of $2.58, up 191.49% year over year. Total DTIL earnings for the quarter were $20.13 million. In the same quarter last year, Precision Biosciences's earnings per share (EPS) was -$2.82.
Is Precision Biosciences profitable or losing money?
As of the last Precision Biosciences earnings report, Precision Biosciences is currently losing money. Precision Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$45.72 million, a 737.98% decrease year over year.
What was DTIL's earnings growth in the past year?
As of Precision Biosciences's earnings date in Q2 2026, Precision Biosciences's earnings has grown year over year. DTIL earnings in the past year totalled -$45.72 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.